We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$367M
AUM Growth
-$15.4M
Cap. Flow
-$423K
Cap. Flow %
-0.12%
Top 10 Hldgs %
41.26%
Holding
60
New
5
Increased
26
Reduced
17
Closed
3

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$10.9M
2
ALLE icon
Allegion
ALLE
+$6.16M
3
HSIC icon
Henry Schein
HSIC
+$2.93M
4
FISV
Fiserv Inc
FISV
+$2.47M
5
EXPE icon
Expedia Group
EXPE
+$2.42M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$10.4M
2
UNVR
Univar Solutions Inc.
UNVR
+$9.07M
3
VMW
VMware, Inc
VMW
+$4.54M
4
JNJ icon
Johnson & Johnson
JNJ
+$2.83M
5
RTX icon
RTX Corp
RTX
+$1.86M

Sector Composition

Rank Sector Weight
1 Technology 25.4%
2 Healthcare 19.61%
3 Financials 14.31%
4 Consumer Staples 14.3%
5 Consumer Discretionary 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.83T
$23.9M 6.53%
75,811
+1,725
+2% +$570K
PM icon
2
Philip Morris
PM
$298B
$18.5M 5.04%
199,720
+15,601
+8% +$1.5M
UNH icon
3
UnitedHealth
UNH
$385B
$15.6M 4.24%
30,859
+1,420
+5% +$699K
JNJ icon
4
Johnson & Johnson
JNJ
$624B
$14.6M 3.99%
93,845
-17,129
-15% -$2.83M
MSI icon
5
Motorola Solutions
MSI
$67.6B
$14.3M 3.89%
52,384
-475
-0.9% -$135K
FISV
6
Fiserv Inc
FISV
$26.6B
$13.9M 3.8%
123,263
+20,059
+19% +$2.47M
MDT icon
7
Medtronic
MDT
$105B
$13.5M 3.68%
172,051
-13,638
-7% -$1.14M
META icon
8
Meta Platforms (Facebook)
META
$1.54T
$12.9M 3.53%
43,118
-2,087
-5% -$629K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$3.89T
$12.7M 3.46%
97,079
+8,616
+10% +$1.11M
ALSN icon
10
Allison Transmission
ALSN
$9.92B
$11.4M 3.11%
193,346
+1,969
+1% +$116K
CSCO icon
11
Cisco
CSCO
$444B
$11M 3.01%
205,022
+8,771
+4% +$473K
MRSH
12
Marsh
MRSH
$84.2B
$10.8M 2.95%
56,900
+2,366
+4% +$453K
BDX icon
13
Becton Dickinson
BDX
$42.1B
$10M 2.73%
38,783
+1,664
+4% +$449K
KVUE icon
14
Kenvue
KVUE
$36.3B
$9.49M 2.59%
+472,720
New +$10.9M
MDLZ icon
15
Mondelez International
MDLZ
$77.1B
$9.42M 2.57%
135,671
+3,459
+3% +$249K
AXP icon
16
American Express
AXP
$233B
$9.31M 2.54%
62,412
-7,822
-11% -$1.28M
KEYS icon
17
Keysight
KEYS
$55.6B
$8.57M 2.34%
64,770
+4,236
+7% +$627K
BKNG icon
18
Booking.com
BKNG
$134B
$8.1M 2.21%
65,675
-15,000
-19% -$1.82M
ROST icon
19
Ross Stores
ROST
$74.5B
$7.32M 2%
64,850
+3,304
+5% +$379K
VMW
20
DELISTED
VMware, Inc
VMW
$7.24M 1.98%
43,513
-28,336
-39% -$4.54M
GNTX icon
21
Gentex
GNTX
$5.07B
$7.22M 1.97%
222,006
-36,908
-14% -$1.18M
HUM icon
22
Humana
HUM
$47.4B
$6.78M 1.85%
13,927
+4,204
+43% +$1.98M
ZBRA icon
23
Zebra Technologies
ZBRA
$12.2B
$6.36M 1.74%
26,905
+1,695
+7% +$460K
GWW icon
24
W.W. Grainger
GWW
$64.6B
$6.04M 1.65%
8,729
-448
-5% -$324K
BRK.B icon
25
Berkshire Hathaway Class B
BRK.B
$1.06T
$5.72M 1.56%
16,323

Similar funds

Foyston, Gordon, & Payne's Q3 2023 Portfolio in Review

As of Q3 2023, Foyston, Gordon, & Payne held 60 positions worth $367M, down 4% from $382M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Foyston, Gordon, & Payne's Q3 2023 filing shows 5 new, 26 increased, 17 reduced and 3 closed positions. Its largest new stake was Kenvue: 472,720 shares worth $9.49M. The largest sale was Novartis, an estimated $10.4M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • Foyston, Gordon, & Payne's largest Q3 2023 buy was Kenvue: 472,720 shares worth $9.49M.
  • Foyston, Gordon, & Payne added most to Fiserv Inc in Q3 2023, an estimated $2.47M increase.
  • Foyston, Gordon, & Payne's biggest Q3 2023 reduction was Novartis, cutting an estimated $10.4M.
  • Foyston, Gordon, & Payne fully exited Univar Solutions Inc. in Q3 2023, selling an estimated $9.07M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 41% of its $367M portfolio in Q3 2023.
  • Foyston, Gordon, & Payne opened 5 new positions and closed 3 in Q3 2023.
  • Foyston, Gordon, & Payne's portfolio value fell 4% quarter-over-quarter to $367M.

Based on Foyston, Gordon, & Payne's 13F filing for Q3 2023, filed 26 Oct 2023.